Gil M. Labrucherie

2012

In 2012, Gil M. Labrucherie earned a total compensation of $1.4M as Senior Vice President and General Counsel at Nektar Therapeutics, a 7% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$330,000
Option Awards$566,310
Salary$488,270
Other$6,503
Total$1,391,083

Labrucherie received $566.3K in option awards, accounting for 41% of the total pay in 2012.

Labrucherie also received $330K in non-equity incentive plan, $488.3K in salary and $6.5K in other compensation.

Rankings

In 2012, Gil M. Labrucherie's compensation ranked 4,843rd out of 11,487 executives tracked by ExecPay. In other words, Labrucherie earned more than 57.8% of executives.

ClassificationRankingPercentile
All
4,843
out of 11,487
58th
Division
Manufacturing
1,689
out of 4,252
60th
Major group
Chemicals And Allied Products
396
out of 1,200
67th
Industry group
Drugs
252
out of 922
73rd
Industry
Pharmaceutical Preparations
198
out of 697
72nd
Source: SEC filing on April 30, 2015.

Labrucherie's colleagues

We found four more compensation records of executives who worked with Gil M. Labrucherie at Nektar Therapeutics in 2012.

2012

Howard Robin

Nektar Therapeutics

Chief Executive Officer

2012

John Nicholson

Nektar Therapeutics

Chief Financial Officer

2012

Rinko Ghosh

Nektar Therapeutics

Senior Vice President and Chief Business Officer

2012

Stephen Doberstein

Nektar Therapeutics

Chief Scientific Officer

News

You may also like